跳至主要内容
临床试验/ITMCTR2000003344
ITMCTR2000003344尚未招募1 期

Peptidomics Profile Characterization and Diagnostic Model Construction for Yang Deficiency Water Retention Syndrome of Heart Failure

Hunan University of Chinese Medicine0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
1 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Diagnostic test

入排标准

年龄范围
40 至 90(—)
性别
Male

入选标准

  • 1. Meet the criteria of heart failure diagnosis in 2018 China heart failure diagnosis and treatment guidelines.
  • 2. The State Administration of traditional Chinese Medicine issued TCM clinical pathway and TCM diagnosis and treatment plan (2017 version) for the TCM diagnosis and treatment plan of heart failure to carry out TCM syndrome differentiation and type diagnosis.
  • 3. Adopt the new classification and diagnosis standard of heart failure. According to the level of ejection fraction (EF), heart failure can be divided into heart failure with decreased ejection fraction (hfref, EF < 40%), heart failure with preserved ejection fraction (HFPEF, EF > 50%), and heart failure with ejection fraction in the critical range of 40% - 49% (hfmref).

排除标准

  • 1. The elderly over 90 years old;
  • 2. Patients with renal insufficiency;
  • 3. Patients with malignant tumors.

研究者

发起方
Hunan University of Chinese Medicine

相似试验

招募中
不适用
Comprehensive analysis of serum peptides as candidate biomarkers for inflammatory bowel diseasesulcerative colitis, Crohn&#39s disease, intestinal Bechet&#39s disease
JPRN-UMIN000037592St. Marianna University School of Medicine700
已完成
不适用
Proteomic analysis for establishing a biomarker panel for the onset of Adult T-cell Leukemia (ATL)
JPRN-UMIN000038467niversity of the Ryukyus85
尚未招募
不适用
Application of proteomics to aid biomarker discovery in smear positive patients of P.vivax and P.falciparum malaria
CTRI/2010/091/000451Department of Biosciences and Bioengineering, Indian Institute of Technology (IIT), Powai, Mumbai- 400 076100
进行中(未招募)
不适用
Evaluación mediante proteómica de biomarcadores proteicos asociados con el tratamiento con Eplerenona versus espironolactona en pacientes post-infarto agudo de miocardio, diabéticos con hipertensión arterial no controlada y disfunción ventricular sistólica leve”Identification of proteomic biomarkers associated with eplerenone treatment versus spironolactone in post-acute coronary syndrome patients, with non-controlled arterial hypertension and ventricular dysfunction - PROMETEODisfunción ventricular leve-moderada post-infarto agudo de miocardio en pacientes diabéticos con hipertensión arterial no controlada.Low-moderate ventricular dysfunction in post-acute coronary syndrome patients with diabetes and non-controlled arterial hypertension.
EUCTR2008-001192-29-ESFundación Investigación y Desarrollo en el Area Cardiovascular
已完成
不适用
The potential of circulating peptides as diagnostic agentsSepsis
JPRN-UMIN000036474niversity of Miyazaki100